Catabasis Pharmaceuticals to Present at 2017 Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Catabasis
Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage
biopharmaceutical company, today announced that Jill C. Milne, Ph.D.,
Chief Executive Officer, will present a corporate and pipeline overview
at the 2017 Wedbush PacGrow Healthcare Conference on Wednesday, August
16, 2017 at 10:20am ET at the Le Parker Meridien Hotel in New York, NY.

A webcast of the presentation will be available in the Investors section
of the Company’s website, www.catabasis.com,
and will be archived for 30 days following the presentation.

About Catabasis
At Catabasis Pharmaceuticals, our mission is
to bring hope and life-changing therapies to patients and their
families. Our SMART (Safely Metabolized And Rationally Targeted) Linker
drug discovery platform enables us to engineer molecules that
simultaneously modulate multiple targets in a disease. We are applying
our SMART Linker^SM platform to build an internal pipeline of
product candidates for rare diseases and plan to pursue partnerships to
develop additional product candidates. For more information on the
Company’s drug discovery platform and pipeline of drug candidates,
please visit www.catabasis.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170809005202/en/